Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Amitriptyline (severe)
Insulin (moderate)
Formoterol (moderate)
Salmeterol (moderate)
Beta blockers (moderate)
Glimepiride (moderate)
Digoxin (moderate)
Desvenlafaxine (moderate)
Linezolid (severe)
Cimetidine (moderate)
Metformin (moderate)
This medicine is used for the short-term treatment of heart failure associated with a heart attack or other heart disorders. It is also used for improving heart function in patients who are undergoing open heart surgery or are on a ventilator. It is also used as a short-term treatment option for cardiac decompensation due to weakened heart muscles.
Increased heart rate (severe)
Chest pain
Changes in blood pressure
Narrowing of blood vessels (severe)
Irregular heartbeat (severe)
Headache
Chest tightness
Shortness of breath
Increase in white blood cell count (severe)
Unusual bleeding or bruising (severe)
Increased urination frequency
Nausea
Skin rash and itching
Fever
Swelling and redness at the injection site
Fast and uncontrolled contractions of the ventricles (severe)
Restlessness (severe)
Shaking and trembling of arms and feet
Anxiety and confusion (severe)
Muscle cramps and stiffness
This medicine is not recommended for use in patients with a known allergy to DOBEX 50mg|ml Injection 5ml , sodium metabisulphite, or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with a narrowing or obstruction in the heart or blood vessels that prevents the heart from filling or pumping blood properly due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with a very low blood volume or an inadequate circulatory filling due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with pheochromocytoma, a tumor of the adrenal glands that causes increased secretion of adrenal hormones, since it may worsen the patient's condition.